Andre Araujo is an accomplished executive with extensive experience in health outcomes and epidemiology. Currently serving as the Executive Director of the RWE Platform at Moderna since September 2023, Araujo previously held the position of Head of Value Evidence & Outcomes (VEO) Real-World Analytics at GSK from January 2020 to September 2023. Before GSK, Araujo was the Director and Senior Research Advisor for US Health Outcomes at Eli Lilly and Company from January 2014 to January 2020. Araujo's career began at New England Research Institutes, Inc. (NERI), where the role of Vice President, Epidemiology was held from June 1996 to December 2013. Araujo holds a Ph.D. in Epidemiology from Yale University, a Master's degree in Sociology from Boston University, and a Bachelor's degree in Sociology from Bridgewater State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices